PROSTATE CANCER

Japan's Tokyo Komagome Hospital Dr. Okamoto and his colleagues selected 144 cases of pancreatic cancer patients, intraoperative radiotherapy and analysis of the efficacy of radiation therapy. Patients were divided into 2 groups: group 1 included 65 patients with unresectable tumors using shunt surgery; Group 2 included 68 cases of patients with tumor resection. In addition, the PWC study, 11 patients with radiation therapy from around the hemodynamic changes of pancreatic arterial infusion chemotherapy after them.

Bicalutamide (Casodex), an anti - androgen-corticosteroids, which can be used as the treatment of advanced prostate cancer assistant drug, may also in the treatment of early prostate cancer play an important role. According to Canada "Medical Post" (2001,37:27), the study of 23 countries into the 8113 cases (38 ~ 93 years) and the limitations of locally advanced prostate cancer were three prospective, double-blind, randomized, placebo-controlled study. 4,052 cases received bicalutamide 150mg per Yue treatment; 4,061 cases were receiving placebo treatment two years and acceptable standard resection or radiotherapy. Right to be diagnosed in patients before diagnosis only radiotherapy. Follow-up medication group 4,052 cases, 4,061 cases placebo group. Results cancer medication group progress risk reduction 47%, the survival rate increased by about 20%. A very small number of patients (including the elderly) because of adverse reactions stopping medication. In each hot flashes and impotence 9% (placebo group were 5.2% and 6.1%).

Baltimore, Johns Hopkins Medical Association's Dr. Elizabeth M. Jaffee and his colleagues on the 14 cases eight weeks before the trip Pancreatoduodenectomy pancreatic adenocarcinoma patients given various doses of allogeneic secreted GM-CSF (granulocyte-macrophage colony-stimulating factor) of the tumor vaccine Test.

12 cases of patients tested with the vaccine after a six-month adjuvant radiotherapy and chemotherapy. Such treatment after six cases in remission after one month by month by month to give three times the original dose immunization.

Tel Aviv E. Wolfson Medical Center Dr. Pinhas P. Schachter and his colleagues evaluated laparoscopy and laparoscopic ultrasonography (EH ultrasonographic, DESD), 67 patients with pancreatic tumor treatment effect. Previous conventional imaging examination revealed that tumor resectability 55 cases, 12 cases could be resection.

The researchers found that laparoscopy and laparoscopic ultrasonography of 40 patients with new information. The Joint Inspection of 30 patients avoid radical resection. In these patients, laparoscopic examination found eight cases of advanced disease, laparoscopic ultrasound examination revealed another 22 cases of advanced disease.